Name | Number of supported studies | Average coverage | |
---|---|---|---|
luminal hormone-sensing cell of mammary gland | 4 studies | 25% ± 7% | |
basal cell | 3 studies | 35% ± 8% |
Insufficient scRNA-seq data for expression of PTHLH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 90% | 322.53 | 1305 / 1445 | 58% | 69.87 | 106 / 183 |
uterus | 74% | 267.65 | 126 / 170 | 53% | 29.69 | 245 / 459 |
bladder | 90% | 292.52 | 19 / 21 | 33% | 24.40 | 167 / 504 |
breast | 86% | 586.08 | 396 / 459 | 37% | 13.71 | 409 / 1118 |
lung | 50% | 46.44 | 289 / 578 | 50% | 63.82 | 576 / 1155 |
brain | 74% | 168.36 | 1961 / 2642 | 24% | 1.81 | 171 / 705 |
blood vessel | 94% | 263.47 | 1250 / 1335 | 0% | 0 | 0 / 0 |
prostate | 86% | 157.80 | 211 / 245 | 2% | 0.16 | 12 / 502 |
adipose | 75% | 124.71 | 906 / 1204 | 0% | 0 | 0 / 0 |
intestine | 65% | 108.56 | 630 / 966 | 8% | 1.20 | 42 / 527 |
thymus | 65% | 90.53 | 426 / 653 | 2% | 0.22 | 10 / 605 |
skin | 52% | 55.59 | 949 / 1809 | 13% | 2.61 | 62 / 472 |
spleen | 65% | 63.47 | 157 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 64% | 55.56 | 29 / 45 |
ovary | 61% | 85.74 | 109 / 180 | 2% | 0.18 | 9 / 430 |
stomach | 51% | 62.02 | 182 / 359 | 4% | 0.32 | 11 / 286 |
pancreas | 5% | 2.56 | 16 / 328 | 43% | 6.58 | 77 / 178 |
heart | 48% | 85.62 | 413 / 861 | 0% | 0 | 0 / 0 |
kidney | 9% | 4.67 | 8 / 89 | 33% | 20.44 | 297 / 901 |
adrenal gland | 6% | 4.03 | 16 / 258 | 16% | 9.32 | 37 / 230 |
liver | 2% | 1.74 | 4 / 226 | 15% | 3.95 | 61 / 406 |
lymph node | 0% | 0 | 0 / 0 | 14% | 1.56 | 4 / 29 |
muscle | 5% | 4.18 | 38 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 1.58 | 15 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.08 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010468 | Biological process | regulation of gene expression |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0008544 | Biological process | epidermis development |
GO_0007565 | Biological process | female pregnancy |
GO_0007267 | Biological process | cell-cell signaling |
GO_0032331 | Biological process | negative regulation of chondrocyte differentiation |
GO_0061182 | Biological process | negative regulation of chondrocyte development |
GO_0046058 | Biological process | cAMP metabolic process |
GO_0030282 | Biological process | bone mineralization |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0001501 | Biological process | skeletal system development |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0032330 | Biological process | regulation of chondrocyte differentiation |
GO_0002076 | Biological process | osteoblast development |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0051428 | Molecular function | peptide hormone receptor binding |
GO_0005179 | Molecular function | hormone activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PTHLH |
Protein name | Parathyroid hormone-related protein (PTH-rP) (PTHrP) [Cleaved into: Osteostatin] Parathyroid hormone-related protein (PTH-rP) (PTHrP) (Parathyroid hormone-like protein) (PLP) [Cleaved into: PTHrP[1-36]; PTHrP[38-94]; Osteostatin (PTHrP[107-139])] PTHLH protein |
Synonyms | hCG_37265 PTHRP |
Description | FUNCTION: Neuroendocrine peptide which is a critical regulator of cellular and organ growth, development, migration, differentiation and survival and of epithelial calcium ion transport. Regulates endochondral bone development and epithelial-mesenchymal interactions during the formation of the mammary glands and teeth. Required for skeletal homeostasis. Promotes mammary mesenchyme differentiation and bud outgrowth by modulating mesenchymal cell responsiveness to BMPs. Up-regulates BMPR1A expression in the mammary mesenchyme and this increases the sensitivity of these cells to BMPs and allows them to respond to BMP4 in a paracrine and/or autocrine fashion. BMP4 signaling in the mesenchyme, in turn, triggers epithelial outgrowth and augments MSX2 expression, which causes the mammary mesenchyme to inhibit hair follicle formation within the nipple sheath (By similarity). Promotes colon cancer cell migration and invasion in an integrin alpha-6/beta-1-dependent manner through activation of Rac1. .; FUNCTION: Osteostatin is a potent inhibitor of osteoclastic bone resorption. . FUNCTION: Neuroendocrine peptide which is a critical regulator of cellular and organ growth, development, migration, differentiation and survival and of epithelial calcium ion transport. Regulates endochondral bone development and epithelial-mesenchymal interactions during the formation of the mammary glands and teeth. Required for skeletal homeostasis. Promotes mammary mesenchyme differentiation and bud outgrowth by modulating mesenchymal cell responsiveness to BMPs. Up-regulates BMPR1A expression in the mammary mesenchyme and this increases the sensitivity of these cells to BMPs and allows them to respond to BMP4 in a paracrine and/or autocrine fashion. BMP4 signaling in the mesenchyme, in turn, triggers epithelial outgrowth and augments MSX2 expression, which causes the mammary mesenchyme to inhibit hair follicle formation within the nipple sheath. .; FUNCTION: Osteostatin is a potent inhibitor of osteoclastic bone resorption. . FUNCTION: Neuroendocrine peptide which is a critical regulator of cellular and organ growth, development, migration, differentiation and survival and of epithelial calcium ion transport. Regulates endochondral bone development and epithelial-mesenchymal interactions during the formation of the mammary glands and teeth. Required for skeletal homeostasis. Promotes mammary mesenchyme differentiation and bud outgrowth by modulating mesenchymal cell responsiveness to BMPs. Up-regulates BMPR1A expression in the mammary mesenchyme and this increases the sensitivity of these cells to BMPs and allows them to respond to BMP4 in a paracrine and/or autocrine fashion. BMP4 signaling in the mesenchyme, in turn, triggers epithelial outgrowth and augments MSX2 expression, which causes the mammary mesenchyme to inhibit hair follicle formation within the nipple sheath. .; FUNCTION: Osteostatin is a potent inhibitor of osteoclastic bone resorption. . FUNCTION: Neuroendocrine peptide which is a critical regulator of cellular and organ growth, development, migration, differentiation and survival and of epithelial calcium ion transport. Regulates endochondral bone development and epithelial-mesenchymal interactions during the formation of the mammary glands and teeth. Required for skeletal homeostasis. Promotes mammary mesenchyme differentiation and bud outgrowth by modulating mesenchymal cell responsiveness to BMPs. Up-regulates BMPR1A expression in the mammary mesenchyme and this increases the sensitivity of these cells to BMPs and allows them to respond to BMP4 in a paracrine and/or autocrine fashion. BMP4 signaling in the mesenchyme, in turn, triggers epithelial outgrowth and augments MSX2 expression, which causes the mammary mesenchyme to inhibit hair follicle formation within the nipple sheath. .; FUNCTION: Osteostatin is a potent inhibitor of osteoclastic bone resorption. . |
Accessions | P12272 Q15252 F5GZD9 ENST00000542963.1 F5H485 ENST00000534890.1 ENST00000539239.5 [P12272-1] Q53XY9 ENST00000535992.5 [P12272-2] ENST00000201015.8 [P12272-2] ENST00000538310.1 [P12272-3] ENST00000395872.5 [P12272-1] ENST00000545234.6 [P12272-1] ENST00000395868.7 [P12272-2] |